FindTrial
Sign In

Use of Bodhivrikshe Kashaya (Peepal bark decoction) in Gout

Etiopathological study of Vatarakta and its samprapti vightan by Bodhivriksha Kashaya - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055693
Enrollment
40
Registered
2023-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

None listed

Sponsors

Rishikul CampusUAUHaridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical symptoms of vaatarakta. Serum uric acid level more than 7.0 mg/dl in male and 6.0 mg/dl in female.

Exclusion criteria

Exclusion criteria: Patients with chronic systemic disorders, rheumatoid arthritis, osteoarthritis. Preganant women. Patients below 18 years and more than 60 years.

Design outcomes

Primary

MeasureTime frame
To study the etiopathology of VataraktaTimepoint: 1 month—

Secondary

MeasureTime frame
To evaluate the effect of bodhivriksh kashaya in view of samprapti vighatan of Vatarakta.Timepoint: 1 month—

Countries

India

Contacts

Public ContactDr Shalini Panwar

Rishikul campus,UAU, Haridwar

drsanjaysingh1970@gmail.com7060754892

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026